• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Multidomain rehabilitation after myocardial infarction improves outcomes in older adults

byMichaela DowlingandKiera Liblik
October 15, 2025
in Cardiology, Chronic Disease, Emergency
Reading Time: 3 mins read
β-blockers linked to improved survival in preserved ejection fraction heart failure
Share on FacebookShare on Twitter

1. In this randomized controlled trial, a multidomain rehabilitation program significantly reduced cardiovascular death and unplanned cardiac hospitalizations in older adults post-myocardial infarction (MI).

2. Program adherence was high, with 75% of participants in the intervention group completing the prescribed rehabilitation.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Cardiac rehabilitation programs are integral to post–MI care, yet frailty, comorbidities, and physical limitations often prevent older adults from fully benefiting. To address this gap, the Physical Activity Intervention in Elderly Patients with Myocardial Infarction (PIpELINe) trial evaluated whether a multidomain rehabilitation program tailored to older adults could reduce cardiovascular morbidity and mortality. The program combined exercise training, dietary guidance, and management of cardiovascular risk factors. Results demonstrated a significant reduction in the composite primary outcome of cardiovascular death or unplanned cardiac hospitalization in the intervention group compared with controls, with consistent benefits observed across subgroup analyses. The intervention was also associated with a lower incidence of several secondary outcomes, including death, cardiovascular death, unplanned hospitalization for cardiovascular causes or heart failure, myocardial infarction, coronary revascularization, cerebrovascular accident, unplanned hospitalization for any reason, infection, and bleeding requiring medical intervention. No serious adverse events were attributed to the intervention, supporting its safety in this high-risk population. Limitations of the study include the selective enrollment of participants who had survived one month post-MI, lack of blinding due to the nature of the intervention, and the inability to isolate the effects of individual program components. Nonetheless, the findings highlight the potential of a structured, multidomain approach to extend the benefits of rehabilitation to older adults following MI, underscoring the need for more accessible and tailored secondary prevention strategies.

Click here to read the study in NEJM

In-Depth [randomized controlled trial]: Acute interventions have reduced the mortality of MI in older adults, yet these patients frequently experience recurrent cardiovascular complications and comorbidities. Rehabilitation programs are often underutilized in this population due to mobility limitations, logistical barriers, and medical complexity, highlighting the need for more accessible interventions. The PIpELINe trial evaluated the efficacy of a multidomain program—including exercise training, dietary guidance, and management of cardiovascular risk factors—for older adults after hospitalization for MI. Eligible participants were over 65 years of age, had been admitted with STEMI or NSTEMI and successfully revascularized, and scored 4/9 on the Short Physical Performance Battery at the one-month post-discharge follow-up. Exclusion criteria were not explicitly reported. Across seven sites, 1283 patients were screened, of whom 512 met eligibility criteria; 342 were randomized to the intervention group and 170 to usual care. Intervention adherence was 75% after excluding 18 participants who died during the study. The primary outcome was the composite of cardiovascular death or unplanned cardiac hospitalization within one year of randomization. Incidence was significantly lower in the intervention group (12.6%) compared with controls (20.6%) (hazard ratio [HR], 0.57; 95% confidence interval [CI], 0.36–0.89; p=0.01). Most secondary outcomes also favored the intervention, with the most significant reductions seen in unplanned hospitalization for heart failure (HR, 0.20; 95% CI, 0.07–0.56), unplanned cardiovascular hospitalization (HR, 0.48; 95% CI, 0.29–0.79), and infection (HR, 0.58; 95% CI, 0.19–1.71). Minimal effects were observed for unplanned hospitalizations due to non-cardiovascular causes (HR, 1.06; 95% CI, 0.55–2.02) and for major bleeding events classified as BARC type 3–5 (HR, 0.99; 95% CI, 0.45–2.19). No serious adverse events were associated with program participation. Overall, the trial demonstrates that a structured multidomain rehabilitation program can significantly reduce cardiovascular mortality and morbidity in older adults post-MI, underscoring the importance of tailored, accessible secondary prevention strategies in this high-risk population.

RELATED REPORTS

Emergency department triaging decisions supported by artificial intelligence (AI) led to improved triaging accuracy and patient flow

A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality

Chronic exposure to particulate matter is associated with increased cardiovascular risk

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: acute coronary syndrome (ACS)cardiologychronic diseaseemergencymyocardial infarctionPhysical Activity Intervention in Elderly Patients with Myocardial Infarction
Previous Post

Moderate-to-vigorous physical activity is associated with reduced risk of dyslipidemia

Next Post

A hybrid chatbot may be effective at increasing pneumococcal vaccine uptake in older adults

RelatedReports

Artificial Intelligence

Emergency department triaging decisions supported by artificial intelligence (AI) led to improved triaging accuracy and patient flow

September 21, 2026
Emergency

A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality

September 16, 2026
Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
Next Post
Medical vaccine exemptions increase after elimination of nonmedical exemptions

A hybrid chatbot may be effective at increasing pneumococcal vaccine uptake in older adults

Shared decision-making tool for antidepressants improves patient and physician satisfaction

Use of a mobile self-help application is associated with increased self-esteem and quality of life in individuals with intellectual disabilities

Unpaid caregivers of older adults experience emotional, physical, and financial difficulty

Traumatic brain injury in later life is associated with increased risk of dementia

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.